MGNX MacroGenics, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 14, 2026
$3,58
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$1,2952tyg. minimum
$5,0852tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$228M
P/E (TTM)
-15.6
EPS (TTM)
$-0.23
Przychody (TTM)
$168M
Twoje odznaki
Zakres 52 tyg.
$1–$5
Ocena Analityków
BUY
Cena Docelowa
$8
P/E
-15.6
ROE
-32.6%
Marża Zysku Netto
-8.7%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
MGNX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.58
Kapitalizacja Rynkowa (MRQ)
$228M
P/E (TTM)
-15.6
EPS (TTM)
$-0.23
Przychody (TTM)
$168M
ROE (TTM)
-32.6%
Zakres 52 tyg.
$1–$5
MGNX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$150M2016-12-31 → 2025-12-31
EPS$-1.182020-12-31 → 2025-12-31
Wolny przepływ pieniężny$-83M2016-12-31 → 2025-12-31
Marża netto-8.7%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | MGNX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -15.6średnia z 5 lat ≈-15.3 | ≈-15.3 | · | · | |
| P/S (TTM) | 1.4średnia z 5 lat ≈5.5 | ≈5.5 | 29.5 | Niedowartościowany | |
| P/B (MRQ) | 5.3średnia z 5 lat ≈2.9 | ≈2.9 | 4.9 | Droższy | |
| Cena / FCF (TTM) | -3.5średnia z 5 lat ≈-4.5 | ≈-4.5 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -3.6średnia z 5 lat ≈-4.7 | ≈-4.7 | · | · | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 4.1średnia z 5 lat ≈2.9 | ≈2.9 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | MGNX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -24.3%średnia z 5 lat ≈-150.1% | ≈-150.1% | -680.6% | Najwyższa półka | |
| Marża EBITDA (TTM) | -20.8%średnia z 5 lat ≈-140.4% | ≈-140.4% | -664.4% | Najwyższa półka | |
| Pretax Margin (Marża przed opodatkowaniem) | -50.4% | · | · | · | |
| Marża Zysku Netto (TTM) | -8.7%średnia z 5 lat ≈-90.0% | ≈-90.0% | -1229.7% | Najwyższa półka | |
| ROA (TTM) | -4.9%średnia z 5 lat ≈-30.3% | ≈-30.3% | -29.4% | Zgodnie z | |
| ROE (TTM) | -32.6%średnia z 5 lat ≈-56.2% | ≈-56.2% | -41.9% | Słaby | |
| ROIC | -129.9% | · | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | MGNX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 3.0średnia z 5 lat ≈4.4 | ≈4.4 | 5.4 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 1.6średnia z 5 lat ≈2.4 | ≈2.4 | 4.6 | Niska płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | MGNX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -0.31%średnia z 5 lat ≈32.7% | ≈32.7% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -0.54%średnia z 5 lat ≈2.2% | ≈2.2% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 7.3% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | MGNX | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.4 | ≈0.4 | 0.1 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 0.0średnia z 5 lat ≈0.8 | ≈0.8 | · | · | |
| Receivables Turnover (Rotacja należności) | 16.9średnia z 5 lat ≈9.7 | ≈9.7 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$510.2K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
16.8%
Następny raport
Lis 10, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 13, 2026 | $-0.26 | $-0.13 | -102.7% |
| 31 marca 2026 | Maj 13, 2026 | $-0.58 | $-0.58 | 0.45% |
| 31 grudnia 2025 | $-0.23 | $-0.30 | 22.4% | |
| 30 września 2025 | $0.27 | $-0.50 | 153.8% | |
| 30 czerwca 2025 | $-0.57 | $-0.62 | 8.1% | |
| 31 marca 2025 | $-0.65 | $-0.80 | 18.5% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $150M | $150M | $59M | $152M | $77M | $105M | $64M | $60M | $158M | $92M | $101M | $48M | |
| Cost of Revenue | $0 | $847.0K | $619.0K | $3M | $3M | $0 | $0 | · | · | · | · | · | |
| R&D Expense | $147M | $177M | $167M | $207M | $215M | $193M | $195M | $191M | $147M | $122M | $98M | $70M | |
| SG&A Expense | $39M | $71M | $52M | $59M | $63M | $43M | $46M | $40M | $33M | $30M | $23M | $16M | |
| Operating Expenses | $222M | $261M | $227M | $273M | $280M | $236M | $241M | $231M | $180M | $152M | $121M | $86M | |
| Operating Income | $-73M | $-111M | $-168M | $-121M | $-203M | $-131M | $-177M | $-171M | $-22M | $-60M | $-20M | $-38M | |
| Interest Expense | · | $1M | $1M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-op | $6M | $9M | $10M | $2M | $680.0K | $1M | $25M | $-247.0K | $3M | $2M | $42.0K | $2.0K | |
| Pretax Income | $-75M | $-66M | $-9M | $-120M | · | · | · | · | · | · | · | · | |
| Income Tax | $-672.0K | $944.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-75M | $-67M | $-9M | $-120M | $-202M | $-130M | $-152M | $-171M | $-20M | $-59M | $-20M | $-38M | |
| EPS (Basic) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | · | · | · | · | · | $-1.40 | |
| EPS (Diluted) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | · | · | · | · | · | $-1.40 | |
| Shares (Basic) | 63,155,096 | 62,621,185 | 61,929,198 | 61,433,124 | 59,944,717 | 52,442,389 | 48,082,728 | · | 36,095,080 | 34,685,274 | 31,801,645 | 27,384,990 | |
| Shares (Diluted) | 63,155,096 | 62,621,185 | 61,929,198 | 61,433,124 | 59,944,717 | 52,442,389 | 48,082,728 | · | 36,095,080 | 34,685,274 | 31,801,645 | 27,384,990 | |
| EBITDA | $-66M | $-103M | $-159M | $-110M | $-192M | $-119M | · | $-163M | $-15M | $-52M | $-17M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $183M | $101M | $109M | $123M | $181M | $126M | $220M | $212M | $84M | $196M | $158M | |
| Short-term Investments | · | · | · | · | · | · | $89M | $13M | $93M | $193M | $143M | · | |
| Receivables | $427.0K | $4M | $10M | $56M | $10M | $23M | $13M | $30M | $14M | $3M | $1M | $3M | |
| Inventory | $8M | $0 | $1M | $1M | $4M | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $12M | $10M | $10M | $21M | $17M | $11M | $7M | $3M | $3M | $2M | $4M | |
| Current Assets | $220M | $217M | $251M | $222M | $280M | $313M | $240M | $269M | $322M | $284M | $342M | $165M | |
| PP&E (Net) | $2M | $18M | $22M | $30M | $38M | $42M | $48M | $57M | $50M | $18M | $15M | $7M | |
| PP&E (Gross) | $108M | $107M | $110M | $114M | $110M | $104M | $98M | $95M | $79M | $44M | $35M | $24M | |
| Accum. Depreciation | $96M | $89M | $88M | $84M | $73M | $62M | $50M | $38M | $29M | $26M | $20M | $17M | |
| Other Non-current Assets | $207.0K | $2M | $1M | $1M | $1M | $24M | $25M | $6M | $2M | $1M | $2M | $2M | |
| Total Assets | $257M | $262M | $298M | $280M | $335M | $379M | $313M | $332M | $374M | $311M | $359M | $174M | |
| Accounts Payable | $3M | $5M | $6M | $5M | $16M | $8M | $4M | $4M | $2M | $4M | $3M | $2M | |
| Accrued Liabilities | $22M | $29M | $24M | $29M | $34M | $34M | $27M | $33M | $39M | $16M | $12M | $8M | |
| Current Liabilities | $43M | $56M | $56M | $49M | $75M | $51M | $45M | $60M | $50M | $27M | $24M | $27M | |
| Capital Leases | $31M | $33M | $30M | $30M | $21M | $25M | $28M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $1M | $2M | $258.0K | $258.0K | $258.0K | $0 | $0 | · | · | · | $0 | · | |
| Total Liabilities | $201M | $146M | $146M | $138M | $96M | $83M | $82M | $89M | $75M | $43M | $46M | $53M | |
| Common Stock | $633.0K | $628.0K | $621.0K | $617.0K | $613.0K | $562.0K | $490.0K | $424.0K | $369.0K | $349.0K | $343.0K | $280.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $335M | |
| Retained Earnings | $-1.24B | $-1.17B | $-1.10B | $-1.09B | $-974M | $-772M | $-642M | $-490M | $-312M | $-293M | $-234M | $-214M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $19.0K | |
| Stockholders' Equity | $56M | $116M | $153M | $142M | $240M | $296M | $231M | $243M | $299M | $269M | $313M | $121M | |
| Liabilities + Equity | $257M | $262M | $298M | $280M | $335M | $379M | $313M | $332M | $374M | $311M | $359M | $174M | |
| Shares Outstanding | 63,318,613 | 62,819,857 | 62,070,627 | 61,701,467 | 61,307,428 | 56,244,771 | 48,958,763 | 42,353,301 | 36,859,077 | 34,870,607 | 34,345,754 | 27,995,638 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $8M | $10M | $12M | $11M | $12M | $12M | $9M | $7M | $8M | $3M | $2M | |
| Stock-based Comp | $14M | $29M | $18M | $20M | $23M | $21M | $20M | $17M | $15M | $12M | $8M | $3M | |
| Other Non-cash | $-28M | $-38M | $-97M | $496.0K | $24M | $-15M | · | $-7M | $12M | $-5M | $-5M | · | |
| Operating Cash Flow | $-81M | $-68M | $-78M | $-87M | $-144M | $-112M | $-134M | $-153M | $14M | $-44M | $-14M | $-33M | |
| CapEx | $2M | $4M | $2M | $4M | $6M | $6M | $4M | $25M | $29M | $11M | $9M | $4M | |
| Investing Cash Flow | $-114M | $149M | $-80M | $71M | $-37M | $-8M | $-79M | $57M | $78M | · | · | · | |
| Stock Issued | $0 | $0 | $616.0K | $1M | $118M | $170M | $119M | $103M | $34M | $0 | $203M | $77M | |
| Net Stock Activity | $0 | $0 | $616.0K | $1M | $118M | $170M | · | $103M | $34M | $0 | $203M | · | |
| Financing Cash Flow | $70M | $960.0K | $150M | $2M | $123M | $174M | $120M | $105M | $35M | · | · | · | |
| Net Change in Cash | $-126M | $82M | $-8M | $-15M | $-58M | $55M | $-94M | $8M | $128M | $-112M | $39M | $41M | |
| Free Cash Flow | $-83M | $-72M | $-80M | $-91M | $-150M | $-118M | · | $-178M | $-15M | $-55M | $-23M | · | |
| Levered FCF | · | $-73M | · | · | · | · | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% | -125.0% | · | -284.8% | -14.0% | -65.3% | -20.0% | · | |
| Net Margin | -49.9% | -44.7% | -15.4% | -78.8% | -261.0% | -123.7% | · | -285.2% | -12.4% | -63.7% | -20.0% | · | |
| Pretax Margin | -50.4% | -44.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -68.7% | -270.0% | -72.1% | -247.3% | -113.6% | · | -271.0% | -9.5% | -57.1% | -16.8% | · | |
| ROA | -28.8% | -23.9% | -3.1% | -38.9% | -56.6% | -37.5% | · | -48.6% | -5.7% | -17.5% | -7.6% | · | |
| ROE | -87.0% | -49.9% | -6.2% | -62.8% | -75.5% | -49.3% | · | -63.2% | -6.9% | -20.1% | -9.3% | · | |
| ROIC | -129.9% | -96.6% | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 3.9 | 4.5 | 4.6 | 3.7 | 6.2 | · | 4.5 | 6.5 | 10.4 | 14.7 | · | |
| Quick Ratio | 1.6 | 3.4 | 2.0 | 3.4 | 1.8 | 4.0 | · | 4.4 | 6.4 | 10.2 | 8.5 | · | |
| Interest Coverage | · | -99.2 | -117.7 | · | · | · | · | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.2 | 0.5 | 0.2 | 0.3 | · | 0.2 | 0.5 | 0.3 | 0.4 | · | |
| Inventory Turnover | 0.0 | 1.4 | 0.5 | 1.1 | 1.2 | · | · | · | · | · | · | · | |
| Receivables Turnover | 16.9 | 20.4 | 1.8 | 4.6 | 4.6 | 5.9 | · | 2.8 | 19.2 | 46.1 | 48.5 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.88 | $1.85 | $2.46 | $2.30 | $3.91 | $5.26 | · | $5.73 | $8.12 | $7.71 | $9.12 | · | |
| Revenue / Share | $2.37 | $2.39 | $0.95 | $2.47 | $1.29 | · | · | · | $4.37 | $2.65 | $3.17 | · | |
| Cash Flow / Share | $-1.28 | $-1.09 | $-1.26 | $-1.42 | $-2.40 | · | · | · | $0.40 | $-1.26 | $-0.43 | · | |
| Cash / Share | $0.90 | $2.91 | $1.63 | $1.76 | $2.01 | $3.22 | · | $5.20 | $5.74 | $2.41 | $5.71 | · | |
| EPS (TTM) | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 | $-2.47 | $-0.70 | $-0.70 | $-0.70 | $-1.73 | $-0.58 | $-1.40 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.31% | 155.3% | -61.3% | 96.2% | -26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.54% | 24.6% | -17.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.3% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $150M | $150M | $59M | $152M | $77M | $105M | $64M | $60M | $158M | $92M | $101M | $48M | |
| Net Income TTM | $-75M | $-67M | $-9M | $-120M | $-202M | $-130M | $-152M | $-171M | $-20M | $-59M | $-20M | $-38M | |
| Market Cap | $102M | $204M | $597M | $414M | $984M | $1.29B | · | $538M | $700M | $713M | $1.06B | · | |
| P/E | -1.4 | -3.0 | -64.1 | -3.4 | -4.8 | -9.3 | -15.5 | -18.1 | -27.1 | -11.8 | -53.4 | -25.1 | |
| P/S | 0.7 | 1.4 | 10.2 | 2.7 | 12.7 | 12.3 | · | 8.9 | 4.4 | 7.8 | 10.5 | · | |
| P/B | 1.8 | 1.8 | 3.9 | 2.9 | 4.1 | 4.3 | · | 2.2 | 2.3 | 2.7 | 3.4 | · | |
| P / Tangible Book | 1.8 | 1.8 | 3.9 | 2.9 | 4.1 | 4.3 | · | · | · | · | · | · | |
| P / Cash Flow | -1.3 | -3.0 | -7.6 | -4.8 | -6.8 | -11.5 | · | -3.5 | 48.6 | -16.3 | -77.9 | · | |
| P / FCF | -1.2 | -2.8 | -7.5 | -4.6 | -6.6 | -10.9 | · | -3.0 | -46.7 | -12.9 | -46.5 | · | |
| Earnings Yield | -73.3% | -32.9% | -1.6% | -29.1% | -21.0% | -10.8% | -6.4% | -5.5% | -3.7% | -8.5% | -1.9% | -4.0% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $21M | $41M | $73M | $7M | $13M | $19M | $111M | $11M | $9M | $10M | $13M | $24M | $73M | $42M | $26M | |
| Cost of Revenue | · | · | $0 | $0 | $0 | $0 | $233.0K | $168.0K | $176.0K | $270.0K | $85.0K | $258.0K | $113.0K | $116.0K | $3M | $180.0K | |
| R&D Expense | $39M | $35M | $34M | $33M | $41M | $40M | $39M | $41M | $52M | $46M | $30M | $43M | $46M | $46M | $48M | $52M | |
| SG&A Expense | $8M | $10M | $9M | $10M | $9M | $11M | $28M | $14M | $14M | $15M | $12M | $14M | $14M | $14M | $15M | $14M | |
| Operating Expenses | $47M | $54M | $53M | $54M | $50M | $56M | $72M | $57M | $69M | $63M | $46M | $58M | $63M | $61M | $67M | $68M | |
| Operating Income | $-14M | $-33M | $-12M | $19M | $-43M | $-43M | $-53M | $54M | $-58M | $-54M | $-36M | $-45M | $-38M | $12M | $-25M | $-42M | |
| Interest Expense | $4M | $5M | · | $3M | $802.0K | $91.0K | · | $0 | $6.0K | $1M | $0 | $774.0K | $656.0K | $0 | $0 | $0 | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | · | · | $819.0K | $142.0K | $504.0K | |
| Pretax Income | $-70M | · | $-15M | $17M | $-43M | · | $-14M | $56M | $-56M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-777.0K | $0 | $105.0K | · | $944.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $20M | $-37M | $-14M | $17M | $-36M | $-41M | $-15M | $56M | $-56M | $-52M | $18M | $57M | $-38M | $13M | $-25M | $-41M | |
| EPS (Basic) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 | $-0.89 | $-0.84 | $0.28 | $0.93 | $-0.61 | $0.20 | $-0.40 | $-0.67 | |
| EPS (Diluted) | $0.31 | $-0.58 | $-0.23 | $0.27 | $-0.57 | $-0.65 | $-0.24 | $0.90 | $-0.89 | $-0.84 | $0.28 | $0.92 | $-0.61 | $0.20 | $-0.40 | $-0.67 | |
| Shares (Basic) | 63,594,453 | 63,449,780 | · | 63,233,266 | 63,136,057 | 62,965,415 | · | 62,744,005 | 62,663,677 | 62,290,538 | 61,980,680 | 61,880,096 | 61,809,817 | · | 61,459,831 | 61,384,943 | |
| Shares (Diluted) | 63,594,453 | 63,449,780 | · | 63,283,624 | 63,136,057 | 62,965,415 | · | 62,865,841 | 62,663,677 | 62,290,538 | 62,244,602 | 62,261,646 | 61,809,817 | · | 61,459,831 | 61,384,943 | |
| EBITDA | $-14M | $-32M | · | $19M | $-37M | $-41M | · | $54M | $-58M | $-52M | $-36M | $-45M | $-35M | · | $-25M | $-42M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $114M | $67M | $57M | $80M | $131M | $146M | $183M | $180M | $84M | $80M | $90M | $109M | $224M | · | $84M | $21M | |
| Receivables | $25M | $10M | $13M | $69M | $13M | $11M | $4M | $9M | $6M | $7M | $25M | $6M | $36M | · | $14M | $18M | |
| Inventory | · | $9M | $8M | $9M | $9M | $9M | $0 | $3M | $1M | $1M | $1M | $1M | $1M | · | $1M | $3M | |
| Prepaid Expense | $4M | $8M | $9M | $8M | $7M | $8M | $12M | $10M | $9M | $10M | $9M | $6M | $10M | · | $9M | $13M | |
| Current Assets | $322M | $183M | $220M | $232M | $205M | $182M | $217M | $222M | $157M | $203M | $291M | $255M | $289M | · | $148M | $168M | |
| PP&E (Net) | $2M | $11M | $13M | $14M | $15M | $17M | $18M | $19M | $20M | $21M | $23M | $24M | $27M | · | $32M | $34M | |
| PP&E (Gross) | · | · | $108M | · | · | · | $107M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $96M | · | · | · | $89M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $195.0K | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | · | $16M | $16M | |
| Total Assets | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M | $201M | $248M | $340M | $306M | $343M | · | $195M | $218M | |
| Accounts Payable | $3M | $4M | $5M | $6M | $5M | $7M | $5M | $7M | $5M | $11M | $3M | $4M | $4M | · | $5M | $3M | |
| Accrued Liabilities | $30M | $18M | $22M | $23M | $21M | $28M | $29M | $25M | $24M | $18M | $25M | $28M | $28M | · | $33M | $32M | |
| Current Liabilities | $109M | $96M | $43M | $44M | $39M | $55M | $56M | $59M | $58M | $56M | $51M | $45M | $46M | · | $50M | $51M | |
| Capital Leases | $30M | $31M | $32M | $32M | $32M | $32M | $33M | $29M | $30M | $30M | $30M | $30M | $30M | · | $17M | $18M | |
| Other Non-current Liabilities | $450.0K | $727.0K | $1M | $1M | $2M | $2M | $2M | $258.0K | $258.0K | $258.0K | $258.0K | $258.0K | $258.0K | · | $258.0K | $258.0K | |
| Total Liabilities | $303M | $197M | $201M | $204M | $199M | $145M | $146M | $144M | $143M | $142M | $146M | $134M | $234M | · | $72M | $76M | |
| Common Stock | $637.0K | $636.0K | $633.0K | $633.0K | $632.0K | $631.0K | $628.0K | $627.0K | $627.0K | $626.0K | $620.0K | $619.0K | $618.0K | · | $615.0K | $615.0K | |
| Retained Earnings | $-1.26B | $-1.28B | $-1.24B | $-1.23B | $-1.25B | $-1.21B | $-1.17B | $-1.15B | $-1.21B | $-1.15B | $-1.06B | $-1.07B | $-1.13B | · | $-1.11B | $-1.08B | |
| Stockholders' Equity | $43M | $21M | $56M | $67M | $47M | $79M | $116M | $120M | $58M | $106M | $194M | $172M | $109M | $142M | $123M | $142M | |
| Liabilities + Equity | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M | $201M | $248M | $340M | $306M | $343M | · | $195M | $218M | |
| Shares Outstanding | 63,645,711 | 63,560,068 | 63,318,613 | 63,258,532 | 63,205,703 | 63,090,323 | 62,819,857 | 62,763,120 | 62,720,969 | 62,560,502 | 62,028,904 | 61,938,493 | 61,838,565 | · | 61,462,189 | 61,458,790 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $2M | $3M | $3M | $4M | $4M | $4M | $11M | $6M | $7M | $6M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-3M | · | · | · | $-12M | · | · | · | $-847.0K | · | · | $17M | · | · | · | |
| Operating Cash Flow | $-41M | $-36M | $43M | $-30M | $-47M | $-47M | $-38M | $60M | $-44M | $-46M | $-35M | $-2M | $-13M | $29M | $-9M | $-49M | |
| CapEx | $806.0K | $344.0K | $244.0K | $426.0K | $715.0K | $529.0K | $620.0K | $592.0K | $1M | $1M | $499.0K | $286.0K | $359.0K | $393.0K | $804.0K | $1M | |
| Investing Cash Flow | $28M | $45M | $-66M | $-20M | $-38M | $10M | $41M | $36M | $47M | $25M | $-34M | $-113M | $28M | $-6M | $72M | $23M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $616.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | $616.0K | · | · | · | |
| Financing Cash Flow | $60M | $-207.0K | $57.0K | $0 | $70M | $-282.0K | $155.0K | $-68.0K | $625.0K | $248.0K | $50M | $59.0K | $100M | $1M | $0 | $263.0K | |
| Net Change in Cash | $47M | $9M | $-23M | $-51M | $-15M | $-37M | $3M | $96M | $4M | $-21M | $-19M | $-116M | $115M | $25M | $63M | $-26M | |
| Free Cash Flow | · | $-36M | · | · | · | $-47M | · | · | · | $-47M | · | · | $-13M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -42.2% | -161.0% | · | 25.6% | -165.3% | -323.1% | · | 48.9% | -538.9% | -590.4% | -341.5% | -342.3% | -156.9% | · | -59.8% | -160.8% | |
| Net Margin | 59.4% | -177.0% | · | 23.1% | -163.0% | -311.1% | · | 50.9% | -515.5% | -573.3% | 168.8% | 437.5% | -155.2% | · | -59.5% | -158.8% | |
| Pretax Margin | -212.1% | · | · | 23.1% | -162.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -42.2% | -152.8% | · | 25.6% | -165.3% | -309.7% | · | 48.9% | -538.9% | -570.2% | -341.5% | -342.3% | -144.7% | · | -59.8% | -160.8% | |
| ROA | 6.6% | -16.6% | · | 6.3% | -16.2% | -17.4% | · | 18.6% | -22.0% | -17.6% | 6.6% | 21.9% | -12.4% | · | -8.5% | -12.8% | |
| ROE | 43.6% | -73.3% | · | 18.0% | -69.4% | -44.3% | · | 35.9% | -48.5% | -48.4% | 11.1% | 36.6% | -26.4% | · | -12.0% | -17.9% | |
| ROIC | -32.3% | · | · | 27.8% | -79.1% | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.9 | · | 5.2 | 5.3 | 3.3 | · | 3.7 | 2.7 | 3.6 | 5.7 | 5.6 | 6.3 | · | 3.0 | 3.3 | |
| Quick Ratio | 1.3 | 0.8 | · | 3.4 | 3.7 | 2.8 | · | 3.2 | 1.6 | 1.6 | 2.2 | 2.6 | 5.7 | · | 2.0 | 0.8 | |
| Interest Coverage | -3.2 | -6.8 | · | 5.6 | -45.8 | -468.4 | · | · | -9696.8 | -47.4 | · | -58.1 | · | · | · | · |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.1 | 0.1 | · | 0.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | · | 1.2 | 0.0 | |
| Receivables Turnover | 1.8 | 2.0 | · | 1.9 | 2.4 | 1.5 | · | 6.5 | 1.7 | 0.4 | 0.5 | 1.1 | 1.0 | · | 3.0 | 0.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.67 | $0.33 | · | $1.06 | $0.74 | $1.25 | · | $1.91 | $0.92 | $1.70 | $3.13 | $2.77 | $1.77 | · | $2.00 | $2.32 | |
| Revenue / Share | $0.52 | $0.33 | · | $1.15 | $0.35 | $0.21 | · | $1.76 | $0.17 | $0.15 | $0.17 | $0.21 | $0.40 | · | $0.68 | $0.42 | |
| Cash Flow / Share | · | $-0.56 | · | · | · | $-0.74 | · | · | · | $-0.73 | · | · | $-0.21 | · | · | · | |
| Cash / Share | $1.79 | $1.05 | · | $1.27 | $2.07 | $2.31 | · | $2.86 | $1.34 | $1.28 | $1.45 | $1.76 | $3.63 | · | $1.37 | $0.35 | |
| EPS (TTM) | $-0.23 | $-1.11 | · | $-1.19 | $-0.56 | $-0.88 | · | $-1.57 | $-2.19 | $-0.38 | $0.79 | $0.11 | $-1.48 | · | $-3.10 | $-3.56 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $168M | $142M | · | $112M | $150M | $154M | · | $141M | $41M | $43M | $121M | $152M | $165M | · | $93M | $67M | |
| Net Income TTM | $-15M | $-70M | · | $-76M | $-36M | $-56M | · | $-98M | $-136M | $-23M | $50M | $7M | $-91M | · | $-191M | $-219M | |
| Market Cap | $294M | $184M | · | $106M | $76M | $80M | · | $206M | $267M | $921M | $289M | $331M | $443M | · | $213M | $181M | |
| P/E | -20.1 | -2.6 | · | -1.4 | -2.2 | -1.4 | · | -2.1 | -1.9 | -38.7 | 5.9 | 48.6 | -4.8 | · | -1.1 | -0.8 | |
| P/S | 1.8 | 1.3 | · | 0.9 | 0.5 | 0.5 | · | 1.5 | 6.5 | 21.2 | 2.4 | 2.2 | 2.7 | · | 2.3 | 2.7 | |
| P/B | 6.9 | 8.7 | · | 1.6 | 1.6 | 1.0 | · | 1.7 | 4.6 | 8.7 | 1.5 | 1.9 | 4.1 | · | 1.7 | 1.3 | |
| P / Tangible Book | 6.9 | 8.7 | · | 1.6 | 1.6 | 1.0 | · | 1.7 | 4.6 | 8.7 | 1.5 | 1.9 | 4.1 | · | 1.7 | 1.3 | |
| P / Cash Flow | · | -5.1 | · | · | · | -1.7 | · | · | · | -20.2 | · | · | -34.6 | · | · | · | |
| Earnings Yield | -5.0% | -38.4% | · | -70.8% | -46.3% | -69.3% | · | -47.7% | -51.5% | -2.6% | 17.0% | 2.1% | -20.6% | · | -89.6% | -120.7% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $150M | $150M | $59M | $152M | $77M |
| Marża Operacyjna % | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% |
| Zysk netto | $-75M | $-67M | $-9M | $-120M | $-202M |
| Rozwodniony EPS | $-1.18 | $-1.07 | $-0.15 | $-1.95 | $-3.37 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.1 | 3.9 | 4.5 | 4.6 | 3.7 |
| Wskaźnik Szybkości | 1.6 | 3.4 | 2.0 | 3.4 | 1.8 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-83M | $-72M | $-80M | $-91M | $-150M |
Właściciele instytucjonalni (13F) 135 emitentów · $217.6M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
135
Wartość posiadanych akcji
$217.6M
Nowe pozycje
40
Zamknięte pozycje
24
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 40 (+4 vs poprzedni kw.) | 24 (+15 vs poprzedni kw.) | 34 (+5 vs poprzedni kw.) | 31 (+3 vs poprzedni kw.) | +3.6M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $23 131 194 | 5 006 752 | 10,63% | Akcje |
| BlackRock, Inc. | $21 618 040 | 4 679 229 | 9,94% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $12 270 766 | 2 656 010 | 5,64% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $12 163 305 | 2 632 750 | 5,59% | Akcje |
| BANK OF AMERICA CORP /DE/ | $11 495 724 | 2 488 252 | 5,28% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $11 391 529 | 2 465 699 | 5,24% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $10 969 248 | 2 374 296 | 5,04% | Akcje |
| RA CAPITAL MANAGEMENT, L.P. | $8 612 493 | 1 864 176 | 3,96% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 409 467 | 1 820 231 | 3,87% | Akcje |
| MACKENZIE FINANCIAL CORP | $7 588 932 | 1 642 626 | 3,49% | Akcje |
| MARSHALL WACE, LLP | $7 466 936 | 1 616 220 | 3,43% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $7 285 810 | 1 576 549 | 3,35% | Akcje |
| VANGUARD GROUP INC | $6 805 375 | 4 226 941 | 3,13% | Akcje |
| Affinity Asset Advisors, LLC | $5 620 720 | 1 216 606 | 2,58% | Akcje |
| D. E. Shaw & Co., Inc. | $4 911 018 | 1 062 991 | 2,26% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4 630 506 | 1 002 274 | 2,13% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $4 621 903 | 1 000 412 | 2,12% | Akcje |
| WASATCH ADVISORS LP | $4 507 536 | 1 559 701 | 2,07% | Akcje |
| STATE STREET CORP | $3 990 123 | 863 663 | 1,83% | Akcje |
| GOLDMAN SACHS GROUP INC | $2 577 964 | 558 001 | 1,18% | Akcje |
| NORTHERN TRUST CORP | $2 384 516 | 516 129 | 1,10% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 940 890 | 420 106 | 0,89% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 940 000 | 420 000 | 0,89% | Akcje |
| TWO SIGMA ADVISERS, LP | $1 923 950 | 1 195 000 | 0,88% | Akcje |
| Walleye Capital LLC | $1 885 653 | 408 150 | 0,87% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $1 753 576 | 379 335 | 0,81% | Akcje |
| DIADEMA PARTNERS LP | $1 729 742 | 374 403 | 0,80% | Akcje |
| PINNACLE ASSOCIATES LTD | $1 174 871 | 254 301 | 0,54% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $1 155 711 | 250 154 | 0,53% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $889 974 | 192 635 | 0,41% | Akcje |
| Man Group plc | $869 433 | 188 189 | 0,40% | Akcje |
| Amundi | $837 352 | 181 245 | 0,38% | Akcje |
| CITADEL ADVISORS LLC | $830 828 | 179 833 | 0,38% | Akcje |
| Informed Momentum Co LLC | $793 277 | 171 705 | 0,36% | Akcje |
| LPL Financial LLC | $786 615 | 170 263 | 0,36% | Akcje |
| SEI INVESTMENTS CO | $760 932 | 164 704 | 0,35% | Akcje |
| ROYAL BANK OF CANADA | $679 000 | 147 058 | 0,31% | Akcje |
| STRS OHIO | $658 350 | 142 500 | 0,30% | Akcje |
| Bank of New York Mellon Corp | $626 272 | 135 557 | 0,29% | Akcje |
| Nuveen, LLC | $608 698 | 131 753 | 0,28% | Akcje |
| ADAR1 Capital Management, LLC | $599 778 | 129 822 | 0,28% | Akcje |
| Squarepoint Ops LLC | $542 286 | 117 378 | 0,25% | Akcje |
| Invesco Ltd. | $475 790 | 102 985 | 0,22% | Akcje |
| Headlands Technologies LLC | $458 249 | 99 188 | 0,21% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $446 689 | 96 686 | 0,21% | Akcje |
| Persistent Asset Partners Ltd | $440 614 | 95 371 | 0,20% | Akcje |
| MORGAN STANLEY | $428 681 | 92 788 | 0,20% | Akcje |
| JANE STREET GROUP, LLC | $387 442 | 83 862 | 0,18% | Akcje |
| FMR LLC | $386 315 | 83 618 | 0,18% | Akcje |
| XTX Topco Ltd | $351 393 | 76 059 | 0,16% | Akcje |
Insiderzy spółki 27 insiderów · 11 dyrektorzy generalni · 15 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Eric Blasius Risser | President and CEO | 12 lutego 2026 A | 77 169 | 0 | 0 | $0 |
| James Karrels | SVP and CFO | 12 lutego 2026 A | 206 037 | 0 | 0 | $0 |
| Jeffrey Stuart Peters | Senior VP, GC, and Secretary | 19 sierpnia 2026 S | 0 | 0 | 1 | $-129 086 |
| Ezio Bonvini | Sr VP, Research & CSO | 17 sierpnia 2026 M | 185 799 | 0 | 0 | $0 |
| Beth Ann Smith | VP, Controller & Treasurer | 12 lutego 2026 A | 12 781 | 0 | 0 | $0 |
| Thomas Spitznagel | Sr VP, Technical Ops | 12 lutego 2026 A | 38 543 | 0 | 0 | $0 |
| Stephen L. Eck | Chief Medical Officer | 15 lutego 2025 M | 29 377 | 0 | 0 | $0 |
| Lynn Cilinski | VP, Controller and Treasurer | 15 lutego 2024 M | 6 213 | 0 | 0 | $0 |
| Jon Marc Wigginton | Sr VP, Clinical Dev. & CMO | 20 lutego 2020 A | 18 930 | 0 | 0 | $0 |
| Kathryn E Stein | SVP, Product Dev. & Regulatory | 7 stycznia 2016 M | 95 555 | 0 | 0 | $0 |
| Stanford John Stewart | V P, Clinical Oncology | 9 października 2013 A | · | 0 | 0 | $0 |
| Karen Jean Ferrante | Dyrektor | 19 maja 2026 A | 14 750 | 0 | 0 | $0 |
| Scott Koenig | Dyrektor | 19 maja 2026 A | 867 240 | 0 | 0 | $0 |
| Scott Thomas Jackson | Dyrektor | 19 maja 2026 A | 14 750 | 0 | 0 | $0 |
| William K Heiden | Dyrektor | 19 maja 2026 A | 114 750 | 0 | 0 | $0 |
| Edward Hurwitz | Dyrektor | 19 maja 2026 A | 47 824 | 0 | 0 | $0 |
| David C Stump | Dyrektor | 19 maja 2026 A | 14 750 | 0 | 0 | $0 |
| Federica F. O'Brien | Dyrektor | 19 maja 2026 A | 14 750 | 0 | 0 | $0 |
| Jay Philip Siegel | Dyrektor | 18 maja 2026 M | 14 750 | 0 | 0 | $0 |
| Meenu Chhabra | Dyrektor | 18 maja 2026 M | 14 750 | 0 | 0 | $0 |
| Kenneth Galbraith | Dyrektor | 13 maja 2021 A | 0 | 0 | 0 | $0 |
| Paulo F Costa | Dyrektor | 13 maja 2021 A | 59 435 | 0 | 0 | $0 |
| Matthew K Fust | Dyrektor | 16 maja 2019 A | 500 | 0 | 0 | $0 |
| Arnold L Oronsky | Dyrektor | 18 lutego 2014 S | 1 708 716 | 0 | 0 | $0 |
| Eran Nadav | Dyrektor | 9 października 2013 A | · | 0 | 0 | $0 |
| Margaret Liu | · | 19 maja 2026 A | 14 750 | 0 | 0 | $0 |
| Atul Saran | · | 28 kwietnia 2017 F | 16 986 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 16 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,47% | 30 054 SH | 2 października 2026 | Dziennie |
| IWC · iShares Trust | 0,06% | 213 537 SH | 11 września 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 513 042 SH | 11 września 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 361 044 SH | 19 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58 897 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 1 532 314 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 29 881 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 20 270 SH | 2 października 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 65 703 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 958 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 666 535 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 925 510 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 105 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 334 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 1 871 NS | 31 lipca 2026 | N-PORT |
| IWN · iShares Trust | · | 55 530 SH | 11 września 2026 | Dziennie |
MGNX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 14 analityków
KUP
Średni cel
$8.50
+137,4%
3 21,4%
Mocne kupno
6 42,9%
Kup
5 35,7%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
4 analityków · 2026-09-30Średnia cel $8.00 +123,5%
← Poniżej wszystkich celów
Aktualna cena $3.58
Niski$4.00
Średnia$8.00
Wysoki$11.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 14, 2026